Insider trades

Beskrovnaya Oxana, Chief Officer of Dyne Therapeutics DYN, has filed 0 purchases and 26 sales on the open market. The latest trade was on 25/03/11.

Beskrovnaya Oxana

Chief Scientific Officer
First filing
23/03/15
Trades
37 trades
Buys / sales
0 / 26
12-month net buying
No record
Last trade
25/03/11

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan25/03/1125/03/132,153 sh$11.38$24,501.14−1.1%
Open-market sale10b5-1 plan25/03/0525/03/071,094 sh$11.83$12,942.02−0.5%
Open-market sale10b5-1 plan25/02/1825/02/252,598 sh$13.95$36,242.1−1.3%
Open-market sale10b5-1 plan24/12/1124/12/112,334 sh$28.12$65,632.08−1.1%
Open-market sale10b5-1 plan24/11/1824/11/182,856 sh$28.20$80,539.2−2.0%
Open-market sale10b5-1 plan24/09/1824/09/192,339 sh$34.55$80,812.45−1.6%
Open-market sale10b5-1 plan24/09/1124/09/112,161 sh$31.89$68,914.29−1.5%
DYN
Open-market sale10b5-1 plan24/08/1924/08/202,636 sh2 trades$45.12avg.$118,939.4−1.8%
Open-market sale24/06/1124/06/112,136 sh$31.34$66,942.24−1.4%
DYN
Open-market sale10b5-1 plan24/05/2024/05/2230,426 sh3 trades$32.96avg.$1,002,751.23−16.9%
DYN
Open-market sale10b5-1 plan24/05/1624/05/172,705 sh2 trades$28.27avg.$76,469.37−1.8%
Open-market sale10b5-1 plan24/03/1124/03/122,081 sh$25.70$53,481.7−1.3%
Open-market sale10b5-1 plan24/03/0724/03/112,373 sh$25.85$61,342.05−1.5%
DYN
Open-market sale10b5-1 plan24/01/03–24/01/0424/01/0487,779 sh4 trades$18.57avg.$1,629,985.42−35.9%
Open-market sale23/12/1123/12/121,467 sh$10.72$15,726.24−0.8%
Open-market sale23/09/1823/09/201,436 sh$9.41$13,512.76−1.7%
Open-market sale23/09/1223/09/131,484 sh$10.41$15,448.44−1.7%
Open-market sale23/06/1323/06/141,475 sh$12.43$18,334.25−1.7%
Open-market sale23/03/1423/03/151,416 sh$13.33$18,875.28−1.6%